Mario G Monteghirfo

Dr. Mario G Monteghirfo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in The Scientific World Journal
Verified
Journal Article
Open access
NGNarcizo Gómez-Villanes
Narcizo Gómez-Villanes
RGRita Girón-Aguilar
Rita Girón-Aguilar
VAVidal Aquino-Zacarías
Vidal Aquino-Zacarías
MMMario G Monteghirfo
Mario G Monteghirfo
María CustodioMaría Custodio
María Custodio
Samuel PizarroSamuel Pizarro
Samuel Pizarro
Olluco ( Ullucus tuberosus Caldas) is an Andean tuber essential in the diet of communities in the Andean regions of South America, generally cultivated at altitudes above 2800 m above sea level. Despite its importance, information on its nutritional composition, particularly protein variability among varieties, is limited. This study determined the total protein content of 50 freeze‐dried olluco varieties by the semimicro Kjeldahl method and evaluated the variability of the protein profile of these varieties by electrophoresis techniques (SDS‐PAGE and ND‐PAGE). The results revealed a wide range of protein content: 20% of the varieties showed high content (10.07–11.55 g/100 g dry weight), 62% medium content (7.00–9.98 g/100 g dry weight), and 18% low content (5.60–6.65 g/100 g dry weight). Analysis of protein profile variability revealed a remarkable similarity in the low molecular weight proteins, especially the intense bands close to 14 and 24 kDa. Cluster analysis of protein patterns obtained by SDS‐PAGE allowed us to establish genetic distances and phylogenetic relationships between the varieties studied. The variability in the protein content of olluco suggests that the region of origin may influence the nutritional composition of the varieties. These findings highlight the protein variability of olluco and its potential as a valuable genetic resource for food security and nutrition in the Andean region.

3 March 2026 in Microbiology Spectrum
Verified
Journal Article
Open access
JPJesus G. M. Pariona
Jesus G. M. Pariona
HPHELI JAIME BARRON PASTOR
HELI JAIME BARRON PASTOR
JAJosé E. Tinedo del Aguila
José E. Tinedo del Aguila
DSDavid Santos-Lázaro
David Santos-Lázaro
DHDoris Huerta-Canales
Doris Huerta-Canales
YLYESICA LLIMPE
YESICA LLIMPE
Acinetobacter baumannii is a leading cause of extensively drug-resistant (XDR) infections in intensive care units (ICUs), with global concern due to its resistance to nearly all antimicrobials. In 2024, the WHO reaffirmed carbapenem-resistant A. baumannii as a critical-priority pathogen. In Peru, over 97% of clinical A. baumannii isolates are carbapenem non-susceptible, yet the genomic features of local strains remain poorly characterized. We performed whole-genome sequencing of 19 XDR A. baumannii isolates collected from ICU patients at Hospital Nacional Dos de Mayo (Lima, Peru) between May 2023 and September 2024. Genomes were analyzed for sequence types (ST), capsular (KL) and lipooligosaccharide (OCL) loci, virulence and resistance genes, and phylogenetic relatedness. All isolates were XDR but remained susceptible to colistin. Fourteen isolates belonged to ST2, forming two closely related subgroups carrying KL2 or KL9 and OCL1, with low SNP distances, suggesting recent clonal expansion. These ST2 genomes lacked bla OXA-23 but carried bla OXA-72 . Two isolates were assigned to ST79, harboring KL13/OCL10 and bla OXA-23 , representing the first report of this resistance gene in Peruvian ST79 strains. Three isolates belonged to ST1079, forming a tight Peruvian clade genetically distant from public ST1079 genomes; all carried KL107/OCL3 and bla OXA-23 , indicating possible local emergence. Our study revealed the emergence in Peru of XDR A. baumannii lineages ST79 and ST1079 harboring bla OXA-23 and the spread of high-risk ST2 clones carrying bla OXA-72 , underscoring the need for enhanced genomic surveillance and targeted infection-control measures. IMPORTANCE: A. baumannii is one of the most problematic hospital pathogens worldwide, often resistant to nearly all available antibiotics. In Peru, the proportion of carbapenem-resistant isolates is among the highest reported globally, yet their genetic background has remained largely unknown. This study provides the first genomic and phylogenomic insight into XDR A. baumannii from a major Peruvian hospital, revealing the spread of high-risk clones belonging to sequence type 2 carrying the OXA-72 carbapenemase, and the emergence of two additional lineages, sequence type 79 and sequence type 1079, both producing OXA-23. These findings demonstrate that multiple resistant lineages are established in Peru, highlighting the urgent need to implement genomic surveillance and infection control measures. Understanding the diversity and dynamics of these lineages is critical to limit their further spread and to guide public health responses in South America.

27 October 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
JBJOSIP LLANOS BANEGAS
JOSIP LLANOS BANEGAS
YLYESICA LLIMPE
YESICA LLIMPE
MMMelina M. Mayorca-Yarihuaman
Melina M. Mayorca-Yarihuaman
RRRoxana del Carmen Medina Rojas
Roxana del Carmen Medina Rojas
MMMario G Monteghirfo
Mario G Monteghirfo
HPHELI JAIME BARRON PASTOR
HELI JAIME BARRON PASTOR
An increasing frequency of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has been documented among pediatric infections in recent decades. This study aimed to analyze the antibiotic susceptibility profiles of ESBL-producing and non-ESBL-producing E. coli isolates, to detect CTX-M groups 1, 2, and 9 among ESBL producers, and to assess the clonal relationships between both groups in pediatric patients. A total of 124 E. coli isolates were recovered from clinical specimens (urine, stool, peritoneal fluid, and tracheal aspirates) collected between April and September 2025 at the Pediatric Emergency Hospital (PEH), Lima, Peru. CTX-M groups were detected by multiplex Polymerase Chain Reaction (mPCR), and clonal relationships were assessed by BOX-PCR. ESBL production was identified in 27.4% of isolates, significantly more frequent in urine samples (p < 0.05) and associated with multidrug-resistant (MDR) or extensively drug-resistant (XDR) profiles (p < 0.001). CTX-M group 1 predominated among ESBL producers (91.3%), while groups 2 and 9 were sporadic (2.9% each). BOX-PCR revealed high genetic heterogeneity, resolving 113 patterns (Simpson’s Index of Discrimination = 0.9986) and 31 ESBL-associated clones. These findings indicate that ESBL-producing E. coli dissemination in this setting is driven by diverse lineages rather than a dominant clone, highlighting the need for continued resistance surveillance.